✦ LIBER ✦

THU-11 Hepatocellular carcinoma – Intraarterial therapies: SIRT or TACE

✍ Scribed by Jakobs, T.F.

Book ID: 122763019
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 55 KB
Volume: 45
Category: Article
ISSN: 1590-8658
DOI: 10.1016/S1590-8658(13)60636-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THU-15 Intraarterial therapies: SIRT or

THU-15 Intraarterial therapies: SIRT or TACE

✍ Helmberger, T. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB

FRI-03 Intraarterial therapies: SIRT or

FRI-03 Intraarterial therapies: SIRT or TACE

✍ Pereira, P.L. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 74 KB

FRI-11 Intra-arterial therapies: SIRT or

FRI-11 Intra-arterial therapies: SIRT or TACE?

✍ de Baère, T. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Combined therapy consisting of intraarte

Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-α for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

✍ Young-Hwa Chung; Il Han Song; Byung-Cheol Song; Geun Chan Lee; Moon Soo Koh; Hyu 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## BACKGROUND. Hepatocellular carcinoma (HCC) patients with major vascular involvement or extrahepatic metastasis are not good candidates for surgery or transarterial chemoembolization (TACE). In this study, the authors evaluated the efficacy of combined therapy with intraarterial cisplatin infusio